SNAP-8

SNAP-8 (SNAP-8 (Acetyl Octapeptide-3)). Topical octapeptide cosmetic ingredient; an elongated analogue of Argireline (Acetyl Hexapeptide-3) that competes with SNAP-25 in the SNARE complex to reduce muscle-contraction-related expression lines.

Commonly discussed uses: topical anti-wrinkle cosmetics (expression lines). There is some human research, though it may be limited, early-phase, or for a narrow indication. Note: most uses are not approved indications.

Mechanism: Topical octapeptide cosmetic ingredient; an elongated analogue of Argireline (Acetyl Hexapeptide-3) that competes with SNAP-25 in the SNARE complex to reduce muscle-contraction-related expression lines.

Reported considerations: topical: rare irritation. There is some human research, though it may be limited, early-phase, or for a narrow indication. Legal topical cosmetic ingredient in AU/US/UK. Not an injectable/therapeutic. This is not a safety endorsement; safety data for unapproved compounds is incomplete.

Commonly cited ranges (educational reference, not a recommendation): low topical ~3-5%, typical topical cosmetic concentration, high topical ~10% (formulation-dependent). Administration: topical. Half-life: topical local action (not a systemic drug).

Australian status: Permitted cosmetic ingredient (topical). Legal topical cosmetic ingredient in AU/US/UK. Not an injectable/therapeutic. General regulatory context: most active peptides are Schedule 4 and require a prescription; import via the Personal Importation Scheme requires a valid Australian prescription for prescription-only goods.

Reconstitution/storage reference: pre-formulated cosmetic (no reconstitution); storage: room temp per product.

Commonly discussed combinations (anecdotal for unapproved compounds): topical with Argireline / Matrixyl in cosmetic serums. Stacking increases interaction/safety uncertainty.